• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SALIX SOLESTA; NONE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SALIX SOLESTA; NONE Back to Search Results
Device Problem Insufficient Information (3190)
Patient Problem Constipation (3274)
Event Date 11/12/2014
Event Type  Injury  
Event Description
Dose or amount: 4cc in four 1 cc units.Frequency: one time.Route: rectal.Diagnosis or reason for use: fecal incontinence following (b)(6) 2013 sphincterotomy.Event abated after use stopped or dose reduced: no.After receiving an injection of solesta, i developed extreme constipation and an inability to empty my bowels.I had no constipation before, either immediately or in the past.The administering physician did not believe this to be a side-effect of solesta, and recommended a laxative, but the adverse affects have persisted now for eight days.The prescribing info for solesta, which i found online, warned not to take an enema for one month after injection of the gel, though the physician has identified an enema as the only alternative treatment of the symptoms i am presenting.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SOLESTA
Type of Device
NONE
Manufacturer (Section D)
SALIX
*
MDR Report Key4284339
MDR Text Key22033635
Report NumberMW5039292
Device Sequence Number1
Product Code LNM
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 11/22/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/22/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Other
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Patient Sequence Number1
Patient Age71 YR
-
-